Ears of the Armadillo: Global Health Research and Neglected Diseases in Texas

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Andrus, Jon ^a   Bottazzi, Maria Elena ^b,c   Chow, Jennifer ^d   Goraleski, Karen A ^e   Fisher Hoch, Susan P ^f   Lambuth, Jocelyn K ^b   Lee, Bruce Y ^g   Margolis, Harold S ^h   McCormick, Joseph B ^f   Melby, Peter ⁱ   Murray, Kristy O ^b   Rico Hesse, Rebeca ^b   Valenzuela, Jesus G ^j   Hotez, Peter J ^b,c,k  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d Research America   (United States)

^e American Society of Tropical Medicine and Hygiene   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

ⁱ UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k RICE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADL DISABILITY; CHAGAS DISEASE; COST EFFECTIVENESS ANALYSIS; CYSTICERCOSIS; DENGUE; DIABETES MELLITUS; DISEASE CONTROL; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EDITORIAL; FUNDING; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; MEDICAL RESEARCH; NEGLECTED DISEASE; NONHUMAN; PATIENT ADVOCACY; PREVALENCE; PUBLIC HEALTH; PUBLIC HEALTH PROBLEM; SKIN LEISHMANIASIS; TOXOCARIASIS; TRICHOMONIASIS; TUBERCULOSIS; TYPHUS; UNITED STATES; VACCINATION; WEST NILE FLAVIVIRUS;

EID: 84879530610     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002021     Document Type: Editorial

References (73)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
2. World Health Organization (2010) Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. Geneva: WHO Press. 172 p.
3. Hotez PJ, (2009) Neglected diseases amid wealth in the United States and Europe. Health Aff (Millwood) 28: 1720-1725.
4. Hotez PJ, Fenwick A, Savioli L, Molyneux DH, (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373: 1570-1575.
5. Hotez PJ, (2008) Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2: e256 doi:10.1371/journal.pntd.0000256.
6. Hotez P, Stillwaggon E, McDonald M, Todman L, DiGrazia L, (2010) National summit on neglected infections of poverty in the United States. Emerg Infect Dis 16: e1.
7. Hotez PJ, Gurwith M, (2011) Europe's neglected infections of poverty. Int J Infect Dis 15: e611-619.
8. Hotez PJ, (2010) Neglected infections of poverty among the indigenous peoples of the arctic. PLoS Negl Trop Dis 4: e606 doi:10.1371/journal.pntd.0000606.
9. Kline K, McCarthy JS, Pearson M, Loukas A, Hotez PJ, (2013) Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 7: e1755 doi:10.1371/journal.pntd.0001755.
10. Fisher-Hoch SP, Vatcheva KP, Laing ST, Hossain MM, Rahbar MH, et al. (2012) Missed opportunities for diagnosis and treatment of diabetes, hypertension, and hypercholesterolemia in a Mexican American population, Cameron County Hispanic Cohort, 2003-2008. Prev Chronic Dis 9: 110298.
11. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300 doi:10.1371/journal.pntd.0000300.
12. Denavas-Walt C, Proctor BD, Smith JC, U.S. Census Bureau (2011) Income, poverty, and health insurance coverage in the United States: 2010. Available: http://www.census.gov/prod/2011pubs/p60-239.pdf. Accessed 25 August 2012.
13. Hotez PJ, (2012) Fighting neglected tropical diseases in Texas and America. BMJ 13: e6112.
14. Barry MA, Bezek S, Serpa JA, Hotez PJ, Woc-Colburn L, (2012) Neglected infections of poverty in Texas and the rest of the United States: management and treatment options. Clin Pharmacol Therap 92: 170-181.
15. Hotez PJ, Bottazzi ME, Dumonteil E, Valenzuela JG, Kamhawi S, et al. (2012) Texas and Mexico: sharing a legacy of poverty and neglected tropical disease. PLoS Negl Trop Dis 6: e1497 doi:10.1371/journal.pntd.0001497.
16. Hotez PJ, Dumonteil E, Woc-Colburn L, Serpa JA, Bezek S, et al. (2012) Chagas disease: "the new HIV/AIDS of the Americas". PLoS Negl Trop Dis 6: e1498 doi:10.1371/journal.pntd.0001498.
17. Barona-Vilar C, Gimenez-Marti MJ, Fraile T, Gonzalez-Steibauer C, Parada C, et al. (2012) Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain). Epidemiol Infect 140: 1896-1903.
18. Centers for Disease Control and Prevention (2010) Congenital transmission of Chagas disease - Virginia, 2010. MMWR Morb Mortal Wkly Rep 61: 477-479.
19. Bern C, Kjos S, Yabsley MJ, Montgomery SP, (2012) Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 24: 655-681.
20. Hanford EJ, Zhan FB, Lu Y, Giordano A, (2007) Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Soc Sci Med 65: 60-79.
21. Sarkar S, Strutz SE, Frank DM, Rivaldi C, Sissel B, et al. (2010) Chagas disease risk in Texas. PLoS Negl Trop Dis 4: e836 doi:10.1371/journal.pntd.0000836.
22. Kjos SA, Snowden KF, Craig TM, Lewis B, Ronald N, et al. (2008) Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol 152: 249-256.
23. McHugh CP, Melby PC, Lafon SG, (1996) Leishmaniasis in Texas: epidemiology and clinical aspects of human cases. Am J Trop Med Hyg 55: 547-555.
24. Wright NA, Davis LE, Aftergut KS, et al. (2008) Cutaneous leishmaniasis in Texas: a northern spread of endemic areas. J Am Acad Dermatol 58: 650-652.
25. Petersen CA, (2009) Leishmaniasis, an emerging disease found in companion animals in the United States. Top Companion Anim Med 24: 182-188.
26. González C, Wang O, Strutz SE, González-Salazar C, Sánchez-Cordero V, et al. (2010) Climate change and risk of leishmaniasis in North America: predictions from ecological niche models of vector and reservoir species. PloS Negl Trop Dis 4: e585 doi:10.1371/journal.pntd.0000585.
27. Serpa JA, Graviss EA, Kass JS, White AC Jr, (2011) Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) 90: 81-86.
28. Won KY, Kruszon-Moran D, Schantz PM, Jones JL, (2008) National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Am J Trop Med Hyg 79: 552-557.
29. Hotez PJ, Wilkins PP, (2009) Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis 3: e400 doi:10.1371/journal.pntd.0000400.
30. Lillibridge KM, Parsons R, Randle Y, Travassos da Rosa APA, Guzman H, et al. (2004) The 2002 introduction of West Nile virus into Harris County, Texas, and area historically endemic for St. Louis Encephalitis. Am J Trop Med Hyg 70: 676-681.
31. Nolan MS, Zangeneh A, Khuwaja SA, Martinez D, Rossmann SN, et al. (2012) Proximity of residence to bodies of water and risk for West Nile virus infection: a case-control study in Houston, Texas. J Biomed Biotechnol doi: http://www.hindawi.com/journals/jbb/2012/159578/. Accessed 28 August 2012">10.1155/2012/159578. Available: http://www.hindawi.com/journals/jbb/2012/159578/. Accessed 28 August 2012.
32. Petersen L (2012) CDC telebriefing on West Nile update. Available: http://www.cdc.gov/media/releases/2012/t0905_west_nile_update.html. Accessed 16 November 2012.
33. Harrigan RJ, Thomassen HA, Buermann W, Cummings RF, Kahn ME, et al. (2010) Economic conditions predict prevalence of West Nile virus. PLoS ONE 5: e15437 doi:10.1371/journal.pone.0015437.
34. Meyer T, Bull L, Holmes K, Pascua R, Travassos da Rosa A, et al. (2007) West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis 13: 1500-1503.
35. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807-1814.
36. Murray KO, Baraniuk S, Resnick M, Arafat R, Kilborn C, et al. (2006) Risk factors for developing encephalitis from West Nile virus infection. Epidemiol Infect 134: 1325-1332.
37. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA, (2006) West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42: 1234-1240.
38. Jean CM, Honarmand S, Louie JK, Glaser CA, (2007) Risk factors for West Nile virus neuroinvasive disease, California. Emerg Infect Dis 13: 1918-1920.
39. Murray KO, Koers E, Baraniuk S, Herrington E, Carter H, (2009) Risk factors for encephalitis from West Nile virus: a matched case-control study using hospitalized controls. Zoonoses Public Health 56: 370-375.
40. Nolan MS, Podoll AS, Hause AM, Akers KM, Finkel KW, et al. (2012) Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS ONE 7: e40374 doi:10.1371/journal.pone.0040374.
41. Brunkard JM, Robles Lopez JL, Ramirez J, Cifuentes E, Rothenberg SJ, et al. (2007) Dengue fever seroprevalence and risk factors, Texas-Mexico border. Emerg Infect Dis 13: 1477-83.
42. Reiter P, Lathrop S, Bunning M, Biggerstaff B, Singer D, et al. (2003) Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 9: 86-89.
43. Ramos MM, Mohammed H, Zielinski-Gutierrez E, Hayden MH, Lopez JLR, et al. (2008) Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico Border: results of a household-based seroepidemiologic survey. Am J Trop Med Hyg 78: 364-369.
44. Radke EG, Gregory CJ, Kintziger KW, Sauber-Schatz EK, Hunsperger EA, et al. (2012) Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 18: 135-137.
45. Bouri N, Sell TK, Franco C, Adalja AA, Henderson DA, et al. (2012) Return of epidemic dengue in the United States: implications for the public health practitioner. Public Health Rep 127: 259-266.
46. Gardner LM, Fajardo D, Waller ST, Wang O, Sarkar S, (2012) A predictive spatial model to quantify the risk of air-travel-associated dengue importation into the United States and Europe. J Trop Med 2012: 1-11.
47. Purcell K, Fergie J, Richman K, Rocha L, (2007) Murine typhus in children in South Texas. Emerg Infect Dis 13: 926-927.
48. Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135: 483-491.
49. Qu HQ, Rentfro AR, Lu Y, Nair S, Hanis CL, et al. (2012) Host susceptibility to tuberculosis: insights from a longitudinal study of gene expression in diabetes. Int J Tuberc Lung Dis 16: 370-372.
50. Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, et al. (2011) The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 15: 1436-1444.
51. Matthews CE, Martinez P, Bagaria U, Hossain MM, Nahm M, et al. (2012) Impaired antibody response may underlie the increased susceptibility of diabetes patients to pneumococcal infections. Infect Immu 19: 1360-1369.
52. Mirza S, Hossain M, Mathews C, Martinez P, Pino P, et al. (2012) Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57: 136-142.
53. Qu HQ, Rentfro AR, Lu Y, Nair S, Hanis CL, et al. (2012) Host susceptibility to tuberculosis: insights from a longitudinal study of gene expression in diabetes. Int J Tuberc Lung Dis 16: 370-372.
54. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634-641.
55. Hotez PJ, Daar AS, (2008) The CNCDs and the NTDs: blurring the lines dividing noncommunicable and communicable chronic diseases. PLoS Negl Trop Dis 2: e312 doi:10.1371/journal.pntd.0000312.
56. Moolani Y, Bukhman G, Hotez PJ, (2012) Neglected tropical diseases as hidden causes of cardiovascular disease. PLoS Negl Trop Dis 6: e1499 doi:10.1371/journal.pntd.0001499.
57. Fredregill CL, Mott GC, Dennett JA, Flatt KL, Bueno R Jr, (2011) Thermal fog efficacy tests against mosquitoes in storm drains in Harris County, Texas 2008-09. J Am Mosq Control Assoc 27: 61-68.
58. National Institutes of Health. Medical Education Partnership Initiative (MEPI). Available: http://www.fic.nih.gov/Programs/Pages/medical-education-africa.aspx. Accessed 7 July 2012.
59. Hotez P, (2010) A national school of tropical medicine and neglected infections of poverty for North America. PLoS Negl Trop Dis 4: e735 doi:10.1371/journal.pntd.0000735.
60. Andrus JK, Quadros CA, Castillo Solórzano C, Roses Periago M, Henderson DA, (2011) Measles and rubella eradication in the Americas. Vaccine 29: D91-D96.
61. Wen JJ, Zago MP, Nunez S, Gupta S, Nunez Burgos F, et al. (2012) Serum proteomic signature of human chagasic patients for the identification of novel protein biomarkers of disease. Mol Cell Proteomics 11: 435-452.
62. Vazquez-Chagoyan JC, Gupta S, Garg NJ, (2011) Vaccine development against Trypanosoma cruzi and Chagas disease. Adv Parasitol 75: 121-146.
63. Lee BY, Bacon KM, Wateska AR, Bottazzi ME, Dumonteil E, et al. (2012) Modeling the economic value of a Chagas' disease therapeutic vaccine. Hum Vaccin Immunother 8: 1-9.
64. Dumonteil E, Bottazzi ME, Zhan B, Heffernan MJ, Jones K, et al. (2012) Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev Vaccines 11: 1043-1055.
65. Saldarriaga OA, Travi BL, Park W, Perez LE, Melby PC, (2006) Immunogenicity of a multicomponent DNA vaccine against vsiceral leishmaniasis in dogs. Vaccine 24: 1928-1940.
66. Lee BY, Bacon KM, Shah M, Kitchen SB, Connor DL, et al. (2012) The economic value of a visceral leishmaniasis vaccine in Bihar State, India. Am J Trop Med Hyg 86: 417-425.
67. Murray KO, Walker G, Gould E, (2011) The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere. Epidemiol Infect 139: 807-817.
68. Schleich K, Numberger C, Sobranski A, Efferth T, (2011) Vaccination and antiviral treatment of neglected diseases caused by flavivirus infections. Curr Med Chem 18: 604-614.
69. Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R, (2012) Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol 2012 86: 7637-7649.
70. Hotez PJ, (2011) New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI). PLoS Negl Trop Dis 5: e1133 doi:10.1371/journal.pntd.0001133.
71. ASTMH Blog. Neglected Infections of Impoverished Americans Act approved by House Committee. Available: http://www.astmh.org/source/blog/post.cfm/house-passes-neglected-infections-of-impoverished-americans-act. Accessed 7 July 2012.
72. Hotez PJ (2008) Forgotten people, forgotten diseases: the neglected tropical diseases and their impact on global health and development. Washington: ASM Press. 218 p.
73. Andrus JK, Jauregui B, De Oliveira LH, Ruiz Matus C, (2011) Challenges to building capacity for evidence-based new vaccine policy in developing countries. Health Aff (Millwood) 30: 1104-1112.